CCR5 and neurodegenerative disease: Notably, the interaction between CCR5 and its ligands activates the MAPK pathway, leading to the production of inflammatory cytokines such as CCL3, CCL4, and CCL5, crucial in the progression of neuroinflammatory and neurodegenerative diseases.11, 12